Alzheimer’s disease (AD)

18F-Florapronol (Alzavue®)

February 3, 2024February 18, 2024
Diagnostics, Positron (β+) emitters, Radiopharmaceuticals

Description 18F-Florapronol (18F-FC119S, Alzavue Injection®, 18F-2-[2-(N-monomethyl)-aminopyridine-6-yl]-6-[(S)-3-fluoro-2-hydroxypropoxy]-benzothiazole) is a radiolabeled tracer developed by FutureChem, which obtained its marketing authorization in South Korea in February 2018. This… Read More »18F-Florapronol (Alzavue®)